Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
experienced a vomiting following immunization with Comirnaty; experienced a 103F fever following immunization with Comirnaty; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): AE-020050 (BioNTech). A 9-month-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset 2025, outcome "unknown", described as "experienced a 103F fever following immunization with Comirnaty"; INFANTILE VOMITING (non-serious) with onset 2025, outcome "unknown", described as "experienced a vomiting following immunization with Comirnaty". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: A friend reported that his 9-month-old son recently experienced a 103F fever and vomiting following immunization with Comirnaty. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
Test Date: 2025; Test Name: Body temperature; Result Unstructured Data: Test Result:103 Fahrenheit